Home / TFRC Knockout Cell Lines

TFRC Knockout Cell Lines

Gene: TFRC

Official Full Name: transferrin receptorprovided by HGNC

Gene Summary: This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO08277 TFRC Knockout cell line (HCT 116) Human TFRC 1:2~1:4 Negative Online Inquiry
KO08278 TFRC Knockout cell line (HEK293) Human TFRC 1:3~1:6 Negative Online Inquiry
KO08279 TFRC Knockout cell line (A549) Human TFRC 1:3~1:4 Negative Online Inquiry

Background

TFRC Gene Knockout Cell Lines are genetically modified cell lines that have had the Transferrin Receptor (TFRC) gene disrupted or knocked out, resulting in an enhanced understanding of cellular processes related to iron homeostasis and cell proliferation. These knockout models allow researchers to investigate the critical role that TFRC plays in cellular function, particularly in iron transport and metabolism, which is essential for various physiological processes, including oxygen transport and DNA synthesis.

The key function of TFRC gene knockout is to enable the study of iron uptake mechanisms and the effects of iron deficiency or overload on cellular health. When TFRC is knocked out, cells exhibit a significantly reduced capacity for transferrin-mediated iron uptake, providing a clear model to observe downstream effects on iron-dependent metabolic pathways and cellular responses. This can be vital in elucidating the pathophysiology of diseases associated with iron dysregulation, including certain anemias and neurodegenerative conditions.

The scientific importance of TFRC Gene Knockout Cell Lines extends to their applications in both research and clinical settings. They serve as vital tools for drug discovery, testing the efficacy of novel therapeutics that target iron metabolism, and can aid in the development of biomarkers for diseases linked to iron imbalance. These models provide a more physiologically relevant system to study the implications of TFRC deficiency in vivo, allowing for more translational insights into human health.

One of the specific advantages of our TFRC Gene Knockout Cell Lines is the precision of the gene editing technique used in their creation, leading to consistent and reproducible results. This reliability is paramount when considering alternatives that may yield variable effects or poor model fidelity. By utilizing our advanced CRISPR/Cas9 technology, these cell lines maintain robust growth characteristics and are well-suited for high-throughput screening applications.

In summary, TFRC Gene Knockout Cell Lines are invaluable for researchers and clinicians looking to explore iron metabolism's critical role in health and disease. Their unique capabilities enable in-depth studies that could lead to critical breakthroughs in understanding various pathologies. Our commitment to providing high-quality biological products, along with our expertise in gene editing technologies, ensures that our offerings remain at the forefront of scientific research and innovation.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.